Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells

Cancer Research

Volumn 60, Issue 14, 2000, Pages 3823-3831

  Wenzel, Uwe ^a   Kuntz, Sabine ^a   Brendel, Mathias D ^a   Daniel, Hannelore ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CYCLOOXYGENASE 2; FLAVONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL X;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL TRANSFORMATION; COLON CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-X PROTEIN; CAMPTOTHECIN; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; CYCLIN B; CYCLIN E; CYCLOOXYGENASE 2; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HT29 CELLS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034660863     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Colon cancer: A review of the epidemiology
2. Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps
3. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro
4. Glucosinolates and phenolics as antioxidants from plant foods
5. Inhibition of bacterial mutagenesis by citrus flavonoids
6. Flavonoids activate wild-type p53
7. Flavonoids: Inhibitors of cytokine induced gene expression
8. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity and apoptosis in human colon cancer cell lines
9. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis
10. Apoptosis, and APC in colorectal tumorigenesis
11. The isolation and culture of adult mouse colonic epithelium
12. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
13. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
14. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis
15. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
16. Increased membrane permeability of apoptotic thymocytes: A flow cytometric study
17. COX-2 inhibitors for colorectal cancer
18. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
19. DNA damage and p53-mediated cell cycle arrest: A reevaluation
20. Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps
21. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms
22. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia
23. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin
24. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer
25. A Phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy
26. Detection of poly(ADP-ribose) polymerase cleavage in response to treatment with topoisomerase I inhibitors: A potential surrogate end point to assess treatment effectiveness
27. WAF1/Cip1protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers
28. p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adeno-carcinomas of the colon: Its relationship with differentiation
29. p53 mutations in colorectal cancer
30. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo
31. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ
32. Cell-cycle arrest versus cell death in cancer therapy
33. Genetic determinants of p53-induced apoptosis and growth arrest
34. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function
35. 2-M arrest following DNA damage in human colon cancer cell lines
36. 1phase arrest in A549 lung adenocarcinoma cells
37. Cancer cell cycles
38. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein
39. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells
40. Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde
41. Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis
42. 2in human colon cancer cells
43. Expression of bcl-2, bax, and bcl-XL proteins in azoxymethane-induced rat colonic adeno-carcinomas
44. Elevated expression of Bcl-X and reduced Bak in primary colorectal adeno-carcinomas
45. Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11)
46. Increased apoptosis accompanies neoplastic development in the human colorectum
47. Transepithelial transport and accumulation of flavone in human intestinal Caco-2 cells